Bharat Biotech's Rotovac Increases The Risk Of Bowel Issues In Infants
A recent study published in the International Journal of Risk and Safety in Medicine has raised concerns about Bharat Biotech's Rotovac, a rotavirus vaccine included in India's government immunization program. According to the study, Rotovac is associated with a 1.6-fold increased risk of intussusception in vaccinated infants. This condition, where part of the intestine folds into an adjacent section, can lead to serious medical complications. Intussusception, also known as bowel "telescoping," is a critical condition where a segment of the intestine slides into the section next to it. This folding can cause an obstruction that prevents food from passing through the intestine. If left untreated, intussusception can lead to severe complications, including bowel gangrene and even death. Immediate medical intervention is crucial to address this condition and prevent fatal outcomes. The study's revelation of a 1.6-fold increased risk of intussusception among in...
